H. R. Franklin

Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

Thomas Cerny, Steven Kaplan, N. Pavlidis et al. · British Journal of Cancer · 1994 · 161 citations · Full text

Non-small-cell Lung Cancer, Phase Ii Trial, Medicine +8

Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

Joost M. Klaase, B.B.R. Kroon, A N van Geel et al. · PubMed · 1994 · 104 citations

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group

Steinar Aamdal, Ingmar Wolff, Steven Kaplan et al. · European Journal of Cancer · 1994 · 82 citations

Malignant Disease, Medicine, Melanoma +8

Systemic leakage during isolated limb perfusion for melanoma

Joost M. Klaase, B.B.R. Kroon, Albertus N. van Geel et al. · British journal of surgery · 1993 · 70 citations

Systemic Leakage, Skin Cancer, Medicine +10

To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater.

H. R. Franklin, H. Schraffordt Koops, J Oldhoff et al. · Journal of Clinical Oncology · 1988 · 52 citations

West Germany, Surgical Oncology, Retrospective Comparative Study +13